PEN
Penumbra IncNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$12.99B
P/E Ratio
72.93
EPS
$4.54
Beta
0.84
52W High
$362.41
52W Low
$221.26
50-Day MA
$340.84
200-Day MA
$287.54
Dividend Yield
—
Profit Margin
12.70%
Forward P/E
64.10
PEG Ratio
0.74
About Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company is headquartered in Alameda, California.
Fundamentals
| Revenue (TTM) | $1.40B |
| Gross Profit (TTM) | $942.44M |
| EBITDA | $206.52M |
| Operating Margin | 15.40% |
| Return on Equity | 13.80% |
| Return on Assets | 7.04% |
| Revenue/Share (TTM) | $36.07 |
| Book Value | $36.39 |
| Price-to-Book | 9.07 |
| Price-to-Sales (TTM) | 9.26 |
| EV/Revenue | 8.99 |
| EV/EBITDA | 56.38 |
| Quarterly Earnings Growth (YoY) | 38.30% |
| Quarterly Revenue Growth (YoY) | 22.10% |
| Shares Outstanding | $39.24M |
| Float | $38.05M |
| % Insiders | 3.00% |
| % Institutions | 95.28% |
Analyst Ratings
Consensus ($365.79 target)
2
Strong Buy2
Buy13
HoldData last updated: 4/9/2026